Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Calandre

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|July 2, 2014
Current status of atypical antipsychotics for the treatment of fibromyalgiaF Rico-Villademoros, E P Calandre, M Slim
Acta Neurologica Scandinavica|April 1, 1991
Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbitalE P Calandre, C Rodriquez-Lopez, A Blazquez, et al.
Cephalalgia : an International Journal of Headache|July 9, 2002
Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illnessE P Calandre, J Bembibre, M L Arnedo, et al.
Clinical Pharmacology and Therapeutics|April 1, 1981
Methapyrilene kinetics and dynamicsE P Calandre, N Alferez, K Hassanein, et al.
Epilepsia|January 1, 1992
The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patientsE P Calandre, B Sinués Porta, D García de la Calzada
European Journal of Neurology|April 19, 2006
Trigger point evaluation in migraine patients: an indication of peripheral sensitization linked to migraine predisposition?E P Calandre, J Hidalgo, J M García-Leiva, et al.
Acta Neurologica Scandinavica|June 1, 1990
Cognitive effects of long-term treatment with phenobarbital and valproic acid in school childrenE P Calandre, R Dominguez-Granados, M Gomez-Rubio, et al.
Pharmacopsychiatry|April 21, 2007
Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trialE P Calandre, P Morillas-Arques, C M Rodriguez-Lopez, et al.
Clinical and Experimental Rheumatology|January 16, 2010
An open-label study of levopromazine (methotrimeprazine) as an add-on therapy in fibromyalgia managementF Rico-Villademoros, J Hidalgo, P Morillas-Arques, et al.
Pharmacopsychiatry|February 20, 2014
Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: an uncontrolled, 12-week, pilot studyE P Calandre, M Slim, J M Garcia-Leiva, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drugs of Today (Barcelona, Spain : 1998)|July 2, 2014
Current status of atypical antipsychotics for the treatment of fibromyalgiaF Rico-Villademoros, E P Calandre, M Slim
Acta Neurologica Scandinavica|April 1, 1991
Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbitalE P Calandre, C Rodriquez-Lopez, A Blazquez, et al.
Cephalalgia : an International Journal of Headache|July 9, 2002
Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illnessE P Calandre, J Bembibre, M L Arnedo, et al.
Clinical Pharmacology and Therapeutics|April 1, 1981
Methapyrilene kinetics and dynamicsE P Calandre, N Alferez, K Hassanein, et al.
Epilepsia|January 1, 1992
The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patientsE P Calandre, B Sinués Porta, D García de la Calzada
European Journal of Neurology|April 19, 2006
Trigger point evaluation in migraine patients: an indication of peripheral sensitization linked to migraine predisposition?E P Calandre, J Hidalgo, J M García-Leiva, et al.
Acta Neurologica Scandinavica|June 1, 1990
Cognitive effects of long-term treatment with phenobarbital and valproic acid in school childrenE P Calandre, R Dominguez-Granados, M Gomez-Rubio, et al.
Pharmacopsychiatry|April 21, 2007
Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trialE P Calandre, P Morillas-Arques, C M Rodriguez-Lopez, et al.
Clinical and Experimental Rheumatology|January 16, 2010
An open-label study of levopromazine (methotrimeprazine) as an add-on therapy in fibromyalgia managementF Rico-Villademoros, J Hidalgo, P Morillas-Arques, et al.
Pharmacopsychiatry|February 20, 2014
Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: an uncontrolled, 12-week, pilot studyE P Calandre, M Slim, J M Garcia-Leiva, et al.
Pageof 2